USARx offers the following ways to purchase this medication. Choose the Best option for you!
Pay this amount and pick up your prescription at ANY Retail pharmacy of your choice! Walgreens, CVS, Walmart, etc.
The easiest way to receive your medications.
Yes76% of Medicare Part D and Medicare Advantage plans cover this drug.
It depends. Which coverage stage are you in? Click on a tab below…
$42 – $395
In the Deductible co-pay stage, you are responsible for the full cost of your prescriptions. Your Medicare deductible cannot exceed $360 in 2016.
Here are some ways that may lower the cost of your incruse ellipta prescription.
If your Medicare co-pay is higher, you can save money by using a USARx coupon instead.
Note: This document contains side effect information about umeclidinium. Some of the dosage forms listed on this page may not apply to the brand name Incruse Ellipta.For the Consumer
Applies to umeclidinium: inhalation powder
Along with its needed effects, umeclidinium (the active ingredient contained in Incruse Ellipta) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking umeclidinium:
Incidence not known
Some side effects of umeclidinium may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
For Healthcare Professionals
Applies to umeclidinium: inhalation powderCardiovascular
Common (1% to 10%): Tachycardia, hypertension, sinus tachycardia (greater than or equal to 1%)
Uncommon (0.1% to 1%): Atrial fibrillation, idioventricular rhythm, supraventricular tachycardia, supraventricular extrasystolesDermatologic
Common (1% to 10%): RashGastrointestinal
Common (1% to 10%): Upper abdominal pain, toothache, dyspepsia (greater or equal to 1%), diarrhea (greater or equal to 1%), nausea (greater or equal to 1%)
Uncommon (0.1% to 1%): Constipation, dry mouthGenitourinary
Common (1% to 10%): Urinary tract infection
Frequency not reported: Worsening of urinary retentionMusculoskeletal
Common (1% to 10%): Arthralgia, myalgia, back pain, neck pain (greater or equal to 1%), pain in extremity (greater or equal to 1%)Nervous system
Common (1% to 10%): Headache, sinus headache (greater or equal to 1%), dizziness (greater or equal to 1%)
Uncommon (0.1% to 1%): DysgeusiaOther
Common (1% to 10%): Contusion, vertigo (greater or equal to 1%)Psychiatric
Common (1% to 10%): Depression (greater or equal to 1%)Respiratory
Common (1% to 10%): Nasopharyngitis, upper respiratory tract infection, viral respiratory tract infection, cough, sinusitis, pneumonia (greater than or equal to 1%), lower respiratory tract infection (greater than or equal to 1%), rhinitis (greater than or equal to 1%), oropharyngeal pain (greater than or equal to 1%)
Uncommon (0.1% to 1%): PharyngitisOcular
Frequency not reported: Worsening of narrow-angle glaucoma (eye pain or discomfort, blurred vision, visual halos or colored images in association with red eyes from conjunctival congestion and corneal edema)
December 16, 2020
March 1, 2021
February 15, 2021
March 1, 2021
February 1, 2021
January 31, 2021